PVCT
$0.05
Provectus Pharma
$.00
(7.69%)
PVCT
Earnings Whisper ®
N/A
Consensus:  $0.00
Revenue:  N/A
Tuesday
Apr 7
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when PVCT reports earnings?
Beat
Meet
Miss

Where is PVCT's stock price going from here?
Up
Flat
Down
Stock chart of PVCT
Analysts
Summary of analysts' recommendations for PVCT
Score
Grade
Pivots
Resistance
$0.07
$0.06
$0.06

$0.05

Support
$0.05
$0.04
$0.04
Tweet
Growth
Description
Provectus Biopharmaceuticals specializes in developing oncology and dermatology therapies. The company's product portfolio consists of PV-10 Melanoma, PH-10 Psoriasis, PH-10 Atopic Dermatitis, PV-10 Breast Cancer, PV-10 Liver Metastasis and PV-10 Mechanism of Action which are in clinical trials. Provectus Biopharmaceuticals Inc., formerly known as Provectus Pharmaceuticals, Inc., is based in Knoxville, Tennessee.